Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of XP19986 in Subjects With Acute Back Spasms

NCT00817986 is registered in ClinicalTrials.gov with XenoPort, Inc. as lead sponsor.

NCT NCT00817986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00817986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of XP19986 in Subjects With Acute Back Spasms
Lead sponsor
XenoPort, Inc.
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2008
Completion date
July 31, 2009
Enrollment
161 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

back pain